Clinical Trial Update: Effect of Linagliptin in Comparison With Glimepiride as Add on to Metformin on Postprandial Beta Cell Function, Postprandial Metabolism and Oxidative Stress in Patients With Type 2 Diabetes Mellitus [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing linagliptin with glimepiride as add-on to metformin in type 2 diabetes, evaluating postprandial beta-cell function, postprand…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Glimepiride (glimepiride)
• Linagliptin (linagliptin)
• metformin (metformin)

Snippet

Sponsor: Marcus Borchert | Conditions: Diabetes Mellitus Type 2 | Phase 4 | Status: UNKNOWN